<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2021</study_start_year><condition>Colorectal adenoma</condition><disease>Colorectal Adenoma</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/35380</full_dataset_link><location>China</location><study_start_month>12</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Clinical evaluation of Canmei formula in the prevention and treatment of recurrence of intestinal adenoma after endoscopic resection</name><description>Intervention group:Canmei formula;Control Group:Berberine hydrochloride
Primary outcome(s): Safety
Study Design: Case-Control study</description><dates><creation>2021-12-15</creation></dates><accession>35380</accession><cross_references><Chinese Clinical Trial Register>ChiCTR2100054824</Chinese Clinical Trial Register><Chinese Medicine Clinical Trials Registry>ChiMCTR2100005456</Chinese Medicine Clinical Trials Registry><International Traditional Medicine Clinical Trial Registry>ITMCTR2100005456</International Traditional Medicine Clinical Trial Registry></cross_references></HashMap>